April 5, 2024- Tune in to a transformative episode of The Cure with Scotty and Sully on Friday, April 5, at 10 AM Central Time, as they welcome the renowned sales expert, Giulio Segantini from underdogsales.com. This episode is set to change the game for sales professionals by turning the often-dreaded task of cold prospecting into a wellspring of opportunity. Giulio … [Read more...]

April 5, 2024- Timothy Reish, M.D., has been named Chair of Orthopedics and Sports Medicine, Pain Management and Podiatry of Summit Health’s NY South region. He has been a practicing Orthopedic Surgeon in New York City for more than 20 years. As a leader in the field, Dr. Reish has published on multiple topics including developing critical pain protocols for outpatient … [Read more...]

April 5, 2024- Cancer mortality has continued to decline nationally. There have been 4 million fewer deaths related to cancer in the U.S. since 1991, according to the American Cancer Society’s (ACS) Cancer Statistics 2024 report. Factors that may be impacting the decline in mortality include fewer people smoking, earlier detection for some cancers, and improved treatment, … [Read more...]

April 5, 2024- Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company's first-of-its-kind TriClip™ transcatheter edge-to-edge repair (TEER) system that's specifically designed for the treatment of tricuspid regurgitation (TR), or a leaky tricuspid valve. This approval follows the recent recommendation of the Circulatory System Devices Panel … [Read more...]

April 5, 2024- Vizient, Inc. released recommendations focused on mitigating common risks, identifying national guidelines and utilizing existing resources to ensure preparedness for an active shooter event. The recommendations were made by a task force of 40 Vizient network executives from 27 organizations across the country. The recommendations and rationales bring attention … [Read more...]

April 5, 2024- Baxter International Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. Adding LVP modality to the Novum IQ Infusion Platform – which includes Baxter’s syringe infusion pump (SYR) with Dose IQ Safety Software, powered by the IQ Enterprise Connectivity Suite – … [Read more...]

April 4, 2024- Teleflex Incorporated announced the upcoming full market release of the Advanced Tissue Control (ATC) feature on its unified UroLift™ 2 System platform designed for the treatment of benign prostatic hyperplasia (BPH) symptoms in men with all prostate types up to 100g. The UroLift™ 2 System with Advanced Tissue Control (UroLift™ 2 ATC) has received FDA … [Read more...]

April 4, 2024- Sysmex America, Inc. announces its plan to sell hemostasis instruments and reagents to laboratories in the United States beginning in April, under the company’s mutual OEM agreement with Siemens Healthineers. With regulatory activities complete, the OEM agreement allows each company to distribute hemostasis instruments (provided by Sysmex) and reagents … [Read more...]

April 4, 2024- QuidelOrtho Corporation has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its QuickVue COVID-19 test. This clearance allows the test to be used with accuracy and convenience in home and medical facility settings with CLIA certificates of waiver. This achievement also reflects QuidelOrtho’s dedication to delivering effective testing … [Read more...]

April 4, 2024- Tenet Healthcare Corporation announced that it has completed the sale of six hospitals and related operations in California consistent with previously disclosed terms. Tenet completed the sale of its four Orange County and Los Angeles County hospitals and related operations to UCI Health – consistent with the approval of the University of California Board of … [Read more...]